Showing 110 of 110on this page. Filters & sort apply to loaded results; URL updates for sharing.110 of 110 on this page
FDA Approves First mRNA RSV Vaccine | MedPage Today
里程碑:首款常规mRNA疫苗来了 Armstrong 2023年7月5日, Moderna 宣布递交RSV mRNA 疫苗mRNA-1345的 ...
Moderna Receives FDA Nod for Single-Dose RSV mRNA Vaccine
Latest mRNA Vaccine for RSV Wins Expedited Review
FDA授予mRNA-1345突破性治疗指定,呼吸道合胞病毒 (RSV) 疫苗达八成以上效力_Moderna_试验_进行
Moderna Granted FDA Breakthrough Therapy Designation for Mrna-1345, an ...
RSV Vaccine 2023: Moderna Granted FDA Breakthrough Therapy Designation ...
Top 5 Most Expected Biologics in 2024 | Mabion
Study: How mRNA-1345 RSV Vaccine Compares to Previously Approved RSV ...
FDA Approves mRNA-1345 Vaccine for Adults Aged 18 to 59 Years
一款成功的RSV疫苗可能会是什么样的? - 知乎
mRNA序列设计案例分享:Moderna RSV疫苗mRNA-1345的序列解析_蛋白_抗原_编码
Highly Effective mRNA-LNP Vaccine Against Respiratory Syncytial Virus ...
P-97. Safety, Tolerability, and Immunogenicity of Revaccination With ...
Investigational RSV Vaccine mRNA-1345: Revaccination Safe in Eligible ...
RSV疫苗mRNA-1345对老年人的呼吸系统疾病的预防效果|呼吸系统|RSV|老年人|呼吸道|疫苗|试验|-健康界
Summary: Updated guidance on respiratory syncytial virus (RSV) vaccines ...
Moderna 获得美国 FDA 批准 RSV 疫苗 mRESVIA - 疫苗网
Safety and immunogenicity of mRNA-1345 RSV vaccine coadministered with ...
Examining Older Adults with mRNA-1345 RSV Vaccine for Humoral ...
234. Safety and Immunogenicity of mRNA-1345, an mRNA-Based RSV Vaccine ...
FDA批准全球首个RSV mRNA疫苗mRESVIA(mRNA-1345)上市-MedSci.cn
Moderna向多国递交mRNA RSV疫苗上市申请 7月5日, Moderna 宣布,已向欧洲药品管理局、瑞士药品管理局和澳大利亚药品管理局 ...
mRNA-1345 Vaccine for RSV Clinical Trial 2024 | Power
mRNA-1345 effective against RSV-associated lower respiratory tract ...
Moderna's mRNA-1345 Vaccine Proves Safe & Effective for RSV in Seniors
Revaccination With mRNA-1345 for RSV Maintains Robust Immunogenicity ...
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults ...
Moderna''s RSV Vaccine mRESVIA(R) Granted FDA Approval
IDWeek 2025: mRNA-1345 RSV vaccine is safe and effective in transplant ...
mRESVIA RSV Vaccine Approved
New FDA Approval: MRESVIA™ (Respiratory Syncytial Virus Vaccine, mRNA)
‘A good day’: FDA approves world’s first RSV vaccine
Moderna (MRNA) Stock Pops on RSV Vaccine Trial Results | InvestorPlace
GSK nabs highly anticipated approval for RSV vaccine Arexvy
FDA Data on Moderna’s 2 RSV Vaccines for Infants Raise Safety Concerns
Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older Adults - PMC
Moderna announces MRNA-1345, an investigational respiratory syncytial ...
禹杭校友 | 生物技术公司Moderna宣布候选疫苗mRNA-1345 2/3期临床试验已完成首例患者给药 - 知乎
Moderna announced mRNA-1345, an investigational RSV Vaccine, met ...
(PDF) Design and preclinical assessment of mRNA-1345 prefusion F ...
モデルナのRSVワクチン「mRNA-1345」、60歳以上のRSVによる下気道疾患の予防に関して画期的治療薬に指定 | AMP[アンプ ...
LOGO
FDA Approves mRNA-1345 Vaccine for Adults Aged 18 to 59 Years ...
IDWeek 2024丨儿童RSV预防:疫苗与单抗临床研究进展_腾讯新闻
Moderna RSV Vaccine Gains Expanded FDA Approval for Younger Adults
FDA Approves mRNA-1345 for Protection Against Lower Respiratory Tract ...
Moderna Files Regulatory Submissions for mRNA-1345 Vaccine Against RSV ...
Moderna RSV Vaccine: A Glimmer of Hope in a Billion-Dollar Race?
First RSV vax review fast-tracked - Medical Republic
Study on the Safety and Immune Response of mRNA-1345 Vaccine for ...
Effectiveness of mRNA-1345 RSV Vaccine: Research & News | Course Hero
Immune correlates analysis of mRNA-1345 RSV vaccine efficacy clinical ...
223. Safety, Tolerability, and Immunogenicity of the mRNA-1345 RSV ...
Safety and Immunogenicity of an mRNA-Based Rsv Vaccine and an Rsv/hMPV ...
全球首款mRNA RSV疫苗获批,但公司股价却大跌,为何?
Pharmacists Play Key Role in Selecting Best RSV Vaccine for Older Adults
Moderna seeks regulatory approval of RSV vaccine for people 60 and ...
(PDF) 234. Safety and Immunogenicity of mRNA-1345, an mRNA-Based RSV ...
呼吸道合胞病毒(RSV)mRNA疫苗!莫德纳mRNA-1345启动关键3期临床研究:用于60岁及以上老年人群! - 专区 - 生物谷
mRNA-1345-Impfstoff offenbar gut wirksam gegen RSV bei Älteren
A self-amplifying RNA RSV prefusion-F vaccine elicits potent immunity ...
Moderna的RSV mRNA疫苗三期临床成功,再创里程碑